Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free ALMU Stock Alerts

Aeluma (ALMU) Financials

Aeluma logo
$13.90 +0.29 (+2.13%)
Closing price 09/22/2026 04:00 PM Eastern
Extended Trading
$13.67 -0.23 (-1.65%)
As of 09/22/2026 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Aeluma

Annual Income Statements for Aeluma

This table shows Aeluma's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025 2026
Period end date 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Total Costs & Expenses		 - - - 6.81 15
Net Income / (Loss) Attributable to Common Shareholders		 -3.45 -5.38 -4.56 -3.02 -9.16
Consolidated Net Income / (Loss)		 -2.69 -5.38 -4.56 -3.02 -9.16
Net Income / (Loss) Continuing Operations		 -2.69 -5.38 -4.56 -3.02 -9.16
Total Pre-Tax Income 		-3.45 -5.38 -4.56 -3.02 -9.16
Total Operating Income		 -3.73 -5.51 -4.56 -2.14 -10
Total Gross Profit		 0.00 0.08 0.30 2.78 1.57
Total Revenue		 0.00 0.19 0.92 4.67 4.46
Operating Revenue		 0.00 0.19 0.92 4.67 4.46
Total Cost of Revenue		 0.00 0.11 0.62 1.88 2.89
Operating Cost of Revenue		 - 0.11 0.62 1.88 2.89
Total Operating Expenses		 2.97 5.59 4.86 4.92 12
Selling, General & Admin Expense		 1.91 3.06 2.36 3.63 7.09
Research & Development Expense		 1.06 2.53 2.51 1.30 4.67
Total Other Income / (Expense), net		 0.28 0.13 0.00 -0.88 1.03
Interest Expense		 - - 0.00 0.72 0.00
Interest & Investment Income		 0.00 0.13 0.00 0.11 1.03
Other Income / (Expense), net		 0.28 - 0.00 -0.28 0.00
Income Tax Expense		 0.00 0.00 0.00 0.00 0.00
Basic Earnings per Share		 ($0.32) ($0.47) ($0.37) ($0.23) ($0.52)
Weighted Average Basic Shares Outstanding		 10.65M 11.38M 12.30M 13.17M 17.67M
Diluted Earnings per Share		 - - ($0.37) ($0.23) ($0.52)
Weighted Average Diluted Shares Outstanding		 10.65M 12.17M 12.30M 13.17M 17.67M
Weighted Average Basic & Diluted Shares Outstanding		 10.65M 12.17M - - 19.27M

Quarterly Income Statements for Aeluma

This table shows Aeluma's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -1.13 -0.96 -0.99 -0.73 -2.90 1.46 -0.86 -1.49 -1.85 -1.80 -4.01
Consolidated Net Income / (Loss)		 -1.13 -0.96 -0.99 -0.73 -2.90 1.46 -0.86 -1.49 -1.85 -1.80 -4.01
Net Income / (Loss) Continuing Operations		 -1.13 -0.96 -0.99 -0.73 -2.90 1.46 -0.86 -1.49 -1.85 -1.80 -4.01
Total Pre-Tax Income 		-1.13 -0.96 -0.99 -0.73 -2.90 1.46 -0.86 -1.49 -1.85 -1.80 -4.01
Total Operating Income		 -1.13 -0.96 -0.99 -0.73 0.39 -2.09 -0.97 -1.61 -2.08 -3.35 -3.15
Total Gross Profit		 0.13 0.11 0.05 0.17 1.03 0.94 0.74 0.68 0.35 0.39 0.15
Total Revenue		 0.26 0.34 0.28 0.48 1.61 1.26 1.32 1.39 1.27 1.22 0.58
Operating Revenue		 0.26 0.34 0.28 0.48 1.61 1.26 1.32 1.39 1.27 1.22 0.58
Total Cost of Revenue		 0.14 0.23 0.23 0.32 0.58 0.31 0.57 0.70 0.92 0.84 0.43
Operating Cost of Revenue		 0.14 0.23 0.23 0.32 0.58 0.31 0.57 0.70 0.92 0.84 0.43
Total Operating Expenses		 1.26 1.07 1.03 0.90 0.64 1.78 1.71 2.29 2.43 2.51 4.52
Selling, General & Admin Expense		 0.60 0.45 0.63 0.50 0.37 1.31 1.56 1.69 1.53 1.63 2.25
Research & Development Expense		 0.65 0.62 0.40 0.40 0.27 0.47 0.15 0.61 0.91 0.88 2.27
Total Other Income / (Expense), net		 0.00 0.00 0.00 0.00 -3.28 2.29 0.11 0.12 0.23 0.33 0.36
Interest & Investment Income		 0.00 0.00 0.00 0.00 0.00 0.00 0.11 0.12 0.23 0.33 0.36
Basic Earnings per Share		 ($0.09) ($0.08) ($0.08) ($0.06) ($0.24) $0.12 ($0.05) ($0.09) ($0.11) ($0.10) ($0.22)
Weighted Average Basic Shares Outstanding		 12.17M 12.18M 12.30M 12.18M 12.21M 12.47M 13.17M 16.14M 17.88M 18.06M 17.67M
Diluted Earnings per Share		 ($0.09) ($0.08) ($0.08) ($0.06) ($0.24) $0.11 ($0.04) ($0.09) ($0.11) ($0.10) ($0.22)
Weighted Average Diluted Shares Outstanding		 12.17M 12.18M 12.30M 12.18M 12.21M 13.21M 13.17M 16.14M 17.88M 18.06M 17.67M
Weighted Average Basic & Diluted Shares Outstanding		 12.18M 12.18M 0.00 - - - 0.00 - - - 19.27M

Annual Cash Flow Statements for Aeluma

This table details how cash moves in and out of Aeluma's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025 2026
Period end date 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Change in Cash & Equivalents		 -3.05 1.33 -3.78 14 40
Net Cash From Operating Activities		 -2.25 -3.64 -3.46 -1.15 -3.27
Net Cash From Continuing Operating Activities		 -2.25 -3.64 -3.46 -1.15 -3.27
Net Income / (Loss) Continuing Operations		 -3.45 -5.38 -4.56 -3.02 -9.16
Consolidated Net Income / (Loss)		 -3.45 -5.38 -4.56 -3.02 -9.16
Depreciation Expense		 0.10 0.21 0.31 0.42 0.45
Amortization Expense		 - 0.66 0.03 0.74 0.00
Non-Cash Adjustments To Reconcile Net Income		 0.26 0.71 0.73 2.17 4.52
Changes in Operating Assets and Liabilities, net		 0.84 0.17 0.03 -1.45 0.92
Net Cash From Investing Activities		 -0.96 -0.67 -0.32 -0.16 -0.65
Net Cash From Continuing Investing Activities		 -0.96 -0.67 -0.32 -0.16 -0.65
Purchase of Property, Plant & Equipment		 -0.50 -0.59 -0.32 -0.16 -0.65
Net Cash From Financing Activities		 0.16 5.64 -0.00 16 44
Net Cash From Continuing Financing Activities		 0.16 5.64 -0.00 16 44
Issuance of Debt		 - - 0.00 3.15 0.00
Issuance of Common Equity		 0.21 5.64 0.00 13 43
Other Financing Activities, net		 -0.05 - 0.00 0.03 0.70

Quarterly Cash Flow Statements for Aeluma

This table details how cash moves in and out of Aeluma's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 -1.33 -0.55 -0.58 2.21 -0.44 13 -0.13 22 0.43 -0.79 18
Net Cash From Operating Activities		 -1.18 -0.40 -0.58 -0.93 -0.40 0.25 -0.07 -0.82 -0.25 -0.58 -1.62
Net Cash From Continuing Operating Activities		 -1.18 -0.40 -0.58 -0.93 -0.40 0.25 -0.07 -0.82 -0.25 -0.58 -1.62
Net Income / (Loss) Continuing Operations		 -1.13 -0.96 -0.99 -0.73 -2.90 1.46 -0.86 -1.49 -1.85 -1.80 -4.01
Consolidated Net Income / (Loss)		 -1.13 -0.96 -0.99 -0.73 -2.90 1.46 -0.86 -1.49 -1.85 -1.80 -4.01
Depreciation Expense		 0.06 0.08 0.10 0.10 0.10 0.11 0.11 0.10 0.11 0.12 0.13
Non-Cash Adjustments To Reconcile Net Income		 0.14 0.19 0.16 0.02 3.15 -1.74 0.74 1.06 1.06 1.10 1.31
Changes in Operating Assets and Liabilities, net		 -0.25 0.29 0.14 -0.47 -1.05 0.14 -0.06 -0.48 0.44 0.01 0.96
Net Cash From Investing Activities		 -0.16 -0.15 -0.01 -0.00 -0.04 -0.04 -0.08 -0.21 -0.03 -0.20 -0.21
Net Cash From Continuing Investing Activities		 -0.16 -0.15 -0.01 -0.00 -0.04 -0.04 -0.08 -0.21 -0.03 -0.20 -0.21
Purchase of Property, Plant & Equipment		 -0.16 -0.15 -0.01 -0.00 -0.04 -0.04 -0.08 -0.21 -0.03 -0.20 -0.21
Net Cash From Financing Activities		 - - 0.00 3.15 - 13 0.02 23 0.71 -0.02 20
Net Cash From Continuing Financing Activities		 - - 0.00 3.15 - 13 0.02 23 0.71 0.04 20
Issuance of Common Equity		 - - - 0.00 - 13 0.00 23 - - 20
Other Financing Activities, net		 - - - 0.00 - 0.01 0.02 0.05 0.71 0.04 -0.09

Annual Balance Sheets for Aeluma

This table presents Aeluma's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025 2026
Period end date 12/31/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Total Assets		 0.15 9.08 5.93 7.16 3.84 19 61
Total Current Assets		 0.04 7.47 4.43 5.33 1.39 17 57
Cash & Equivalents		 0.04 6.79 3.74 5.07 1.29 3.63 56
Short-Term Investments		 - - - - 0.00 12 0.00
Accounts Receivable		 - - 0.00 0.19 0.06 0.96 0.34
Prepaid Expenses		 0.00 0.02 0.03 0.02 0.02 0.63 0.97
Plant, Property, & Equipment, net		 0.12 0.13 0.99 1.46 1.47 1.22 1.42
Plant, Property & Equipment, gross		 0.12 0.13 1.08 1.76 2.08 2.24 2.89
Accumulated Depreciation		 - 0.00 0.10 0.30 0.61 1.02 1.47
Total Noncurrent Assets		 0.00 1.48 0.51 0.37 0.98 0.85 1.94
Other Noncurrent Operating Assets		 0.00 1.47 0.50 0.36 0.98 0.85 1.94
Total Liabilities & Shareholders' Equity		 0.15 9.08 5.93 7.16 3.84 19 61
Total Liabilities		 0.15 0.90 0.83 1.05 1.57 1.51 3.73
Total Current Liabilities		 0.15 0.29 0.37 0.76 0.63 0.71 1.89
Accounts Payable		 0.01 0.13 0.22 0.59 0.50 0.57 1.71
Other Current Liabilities		 0.00 0.16 0.16 0.16 0.13 0.14 0.18
Total Noncurrent Liabilities		 0.00 0.61 0.46 0.30 0.94 0.80 1.84
Other Noncurrent Operating Liabilities		 - - - - 0.94 0.80 1.84
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 0.01 8.19 5.10 6.11 2.28 18 57
Total Preferred & Common Equity		 0.01 8.19 5.10 6.11 2.28 18 57
Preferred Stock		 - 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 0.01 8.19 5.10 6.11 2.28 18 57
Common Stock		 0.02 8.42 8.78 15 16 35 83
Retained Earnings		 -0.01 -0.23 -3.68 -9.06 -14 -17 -26

Quarterly Balance Sheets for Aeluma

This table presents Aeluma's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026
Total Assets		 6.50 5.33 4.72 6.35 6.76 19 43 43 43
Total Current Assets		 4.02 2.80 2.14 4.03 4.53 17 40 40 40
Cash & Equivalents		 3.76 2.42 1.87 3.50 3.06 3.87 26 39 38
Short-Term Investments		 - - - - - 12 12 0.00 0.00
Accounts Receivable		 0.01 0.19 0.15 0.32 1.32 1.14 1.25 1.00 1.06
Prepaid Expenses		 0.22 0.16 0.10 0.19 0.14 0.21 0.83 0.69 1.33
Plant, Property, & Equipment, net		 1.39 1.49 1.56 1.37 1.31 1.25 1.33 1.25 1.33
Plant, Property & Equipment, gross		 1.76 1.92 2.07 2.08 2.12 2.16 2.45 2.48 2.68
Accumulated Depreciation		 0.37 0.43 0.51 0.71 0.81 0.91 1.12 1.23 1.34
Total Noncurrent Assets		 1.09 1.04 1.02 0.95 0.92 0.89 1.10 1.06 1.01
Other Noncurrent Operating Assets		 1.08 1.03 1.01 0.94 0.91 0.88 1.10 1.06 1.01
Total Liabilities & Shareholders' Equity		 6.50 5.33 4.72 6.35 6.76 19 43 43 43
Total Liabilities		 1.64 1.46 1.62 4.64 7.79 1.36 1.76 1.77 2.43
Total Current Liabilities		 0.60 0.45 0.65 2.63 0.49 0.53 0.77 0.83 1.54
Accounts Payable		 0.48 0.33 0.52 0.45 0.36 0.39 0.58 0.63 1.34
Other Current Liabilities		 0.12 0.12 0.13 2.18 0.13 0.14 0.19 0.19 0.20
Total Noncurrent Liabilities		 1.04 1.01 0.97 2.00 7.30 0.84 0.99 0.94 0.89
Capital Lease Obligations		 1.04 1.01 0.97 0.91 0.87 - - - 0.89
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 4.86 3.87 3.10 1.71 -1.03 18 41 41 40
Total Preferred & Common Equity		 4.86 3.87 3.10 1.71 -1.03 18 41 41 40
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 4.86 3.87 3.10 1.71 -1.03 18 41 41 40
Common Stock		 15 16 16 16 16 34 59 61 62
Retained Earnings		 -11 -12 -13 -14 -17 -16 -18 -20 -22

Annual Metrics And Ratios for Aeluma

This table displays calculated financial ratios and metrics derived from Aeluma's official financial filings.

Metric 2022 2023 2024 2025 2026
Period end date 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
DEI Shares Outstanding		 10,650,002.00 12,817,500.00 12,178,424.00 12,178,424.00 12,178,424.00
DEI Adjusted Shares Outstanding		 10,650,002.00 12,817,500.00 12,178,424.00 12,178,424.00 12,178,424.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.32 -0.42 -0.37 -0.25 -0.75
Growth Metrics		 - - - - -
Revenue Growth		 0.00% 0.00% 375.33% 407.62% -4.37%
EBITDA Growth		 0.00% -38.33% 9.09% 69.90% -666.54%
EBIT Growth		 0.00% -59.53% 17.18% 46.96% -320.91%
NOPAT Growth		 0.00% -47.57% 17.18% 53.06% -375.54%
Net Income Growth		 0.00% -100.09% 15.20% 33.76% -203.08%
EPS Growth		 0.00% 0.00% 0.00% 37.84% -126.09%
Operating Cash Flow Growth		 0.00% -61.49% 5.03% 66.77% -184.49%
Free Cash Flow Firm Growth		 0.00% 0.00% 15.70% 6.04% -120.71%
Invested Capital Growth		 0.00% -26.56% -26.22% 119.09% -57.09%
Revenue Q/Q Growth		 0.00% 0.00% 10.37% 28.60% -14.15%
EBITDA Q/Q Growth		 0.00% 0.00% 0.52% -25.00% -54.21%
EBIT Q/Q Growth		 0.00% 0.00% 4.82% -11.92% -50.93%
NOPAT Q/Q Growth		 0.00% 0.00% 4.82% 0.94% -50.93%
Net Income Q/Q Growth		 0.00% 0.00% 6.55% 4.14% -52.55%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% -52.94%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 9.44% 30.90% -91.22%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% -85.10% -1.85%
Invested Capital Q/Q Growth		 0.00% 0.00% -55.25% 1.25% -71.04%
Profitability Metrics		 - - - - -
Gross Margin		 0.00% 43.42% 32.64% 59.61% 35.24%
EBITDA Margin		 0.00% -2,400.32% -459.09% -27.22% -218.22%
Operating Margin		 0.00% -2,849.75% -496.52% -45.92% -228.33%
EBIT Margin		 0.00% -2,849.75% -496.52% -51.88% -228.33%
Profit (Net Income) Margin		 0.00% -2,782.46% -496.41% -64.78% -205.31%
Tax Burden Percent		 77.89% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 99.94% 97.64% 99.98% 124.88% 89.92%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% -244.64% -275.35% -95.41% -462.40%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -206.84% -230.25% -77.53% -456.74%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 148.67% 166.55% 65.45% 437.92%
Return on Equity (ROE)		 -40.47% -95.98% -108.80% -29.96% -24.48%
Cash Return on Invested Capital (CROIC)		 0.00% -214.01% -245.17% -170.05% -382.50%
Operating Return on Assets (OROA)		 0.00% -84.15% -82.90% -20.82% -25.44%
Return on Assets (ROA)		 0.00% -82.16% -82.89% -26.00% -22.88%
Return on Common Equity (ROCE)		 -40.47% -95.98% -108.80% -29.96% -24.48%
Return on Equity Simple (ROE_SIMPLE)		 -52.72% -88.04% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -2.61 -3.86 -3.19 -1.50 -7.13
NOPAT Margin		 0.00% -1,994.83% -347.56% -32.14% -159.83%
Net Nonoperating Expense Percent (NNEP)		 -2.29% -37.80% -45.10% -17.88% -5.66%
Return On Investment Capital (ROIC_SIMPLE)		 - - -140.34% -8.38% -12.52%
Cost of Revenue to Revenue		 0.00% 56.58% 67.36% 40.39% 64.76%
SG&A Expenses to Revenue		 0.00% 1,583.75% 256.37% 77.77% 158.93%
R&D to Revenue		 0.00% 1,309.42% 272.80% 27.76% 104.64%
Operating Expenses to Revenue		 0.00% 2,893.17% 529.16% 105.53% 263.57%
Earnings before Interest and Taxes (EBIT)		 -3.45 -5.51 -4.56 -2.42 -10
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -3.35 -4.64 -4.22 -1.27 -9.74
Valuation Ratios		 - - - - -
Price to Book Value (P/BV)		 0.00 0.00 19.39 12.04 6.85
Price to Tangible Book Value (P/TBV)		 0.00 0.00 19.44 12.05 6.85
Price to Revenue (P/Rev)		 0.00 0.00 48.01 46.21 87.44
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 43.48 92.60 360.75
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 46.60 42.84 74.88
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - -
Debt to Equity		 0.09 0.05 0.00 0.00 0.00
Long-Term Debt to Equity		 0.09 0.05 0.00 0.00 0.00
Financial Leverage		 -0.64 -0.72 -0.72 -0.84 -0.96
Leverage Ratio		 1.13 1.17 1.31 1.15 1.07
Compound Leverage Factor		 1.13 1.14 1.31 1.44 0.96
Debt to Total Capital		 8.25% 4.63% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 8.25% 4.63% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 91.75% 95.37% 100.00% 100.00% 100.00%
Debt to EBITDA		 -0.14 -0.06 0.00 0.00 0.00
Net Debt to EBITDA		 0.98 1.03 0.00 0.00 0.00
Long-Term Debt to EBITDA		 -0.14 -0.06 0.00 0.00 0.00
Debt to NOPAT		 -0.18 -0.08 0.00 0.00 0.00
Net Debt to NOPAT		 1.26 1.24 0.00 0.00 0.00
Long-Term Debt to NOPAT		 -0.18 -0.08 0.00 0.00 0.00
Altman Z-Score		 0.00 0.00 8.48 85.43 62.73
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - -
Current Ratio		 11.90 7.05 2.22 24.59 30.32
Quick Ratio		 10.04 6.95 2.15 23.69 29.81
Cash Flow Metrics		 - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -3.37 -2.84 -2.67 -5.90
Operating Cash Flow to CapEx		 -447.23% -616.56% -1,072.98% -713.04% -505.57%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 -3.74 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 -1.61 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 -1.83 0.00
Efficiency Ratios		 - - - - -
Asset Turnover		 0.00 0.03 0.17 0.40 0.11
Accounts Receivable Turnover		 0.00 0.00 7.37 9.13 6.85
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.16 0.63 3.47 3.39
Accounts Payable Turnover		 0.00 0.27 1.13 3.54 2.54
Days Sales Outstanding (DSO)		 0.00 0.00 49.50 39.98 53.27
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 1,351.86 322.22 103.16 143.84
Cash Conversion Cycle (CCC)		 0.00 -1,351.86 -272.72 -63.18 -90.57
Capital & Investment Metrics		 - - - - -
Invested Capital		 1.82 1.34 0.99 2.16 0.93
Invested Capital Turnover		 0.00 0.12 0.79 2.97 2.89
Increase / (Decrease) in Invested Capital		 0.00 -0.48 -0.35 1.17 -1.23
Enterprise Value (EV)		 0.00 0.00 43 200 334
Market Capitalization		 0.00 0.00 44 216 390
Book Value per Share		 $0.48 $0.48 $0.19 $1.36 $3.22
Tangible Book Value per Share		 $0.48 $0.48 $0.18 $1.36 $3.22
Total Capital		 5.56 6.41 2.28 18 57
Total Debt		 0.46 0.30 0.00 0.00 0.00
Total Long-Term Debt		 0.46 0.30 0.00 0.00 0.00
Net Debt		 -3.28 -4.78 -1.29 -16 -56
Capital Expenditures (CapEx)		 0.50 0.59 0.32 0.16 0.65
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.32 -0.49 -0.53 0.89 -0.59
Debt-free Net Working Capital (DFNWC)		 4.06 4.58 0.77 17 55
Net Working Capital (NWC)		 4.06 4.58 0.77 17 55
Net Nonoperating Expense (NNE)		 0.08 1.52 1.37 1.52 2.03
Net Nonoperating Obligations (NNO)		 -3.28 -4.78 -1.29 -16 -56
Total Depreciation and Amortization (D&A)		 0.10 0.87 0.34 1.15 0.45
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% -255.97% -57.13% 19.08% -13.11%
Debt-free Net Working Capital to Revenue		 0.00% 2,367.24% 83.35% 356.48% 1,242.34%
Net Working Capital to Revenue		 0.00% 2,367.24% 83.35% 356.48% 1,242.34%
Earnings Adjustments		 - - - - -
Adjusted Basic Earnings per Share		 ($0.32) ($0.47) ($0.37) ($0.23) ($0.52)
Adjusted Weighted Average Basic Shares Outstanding		 10.65M 11.38M 12.30M 13.17M 17.67M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 ($0.23) ($0.52)
Adjusted Weighted Average Diluted Shares Outstanding		 10.65M 12.17M 0.00 13.17M 17.67M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 10.65M 12.17M 0.00 0.00 19.27M
Normalized Net Operating Profit after Tax (NOPAT)		 -2.61 -3.86 -3.19 -1.50 -7.13
Normalized NOPAT Margin		 0.00% -1,994.83% -347.56% -32.14% -159.83%
Pre Tax Income Margin		 0.00% -2,782.46% -496.41% -64.78% -205.31%
Debt Service Ratios		 - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 -3.38 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 -2.10 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 -3.61 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 -2.32 0.00
Payout Ratios		 - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% -0.09% 0.00% 0.00%

Quarterly Metrics And Ratios for Aeluma

This table displays calculated financial ratios and metrics derived from Aeluma's official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 12,167,930.00 12,178,424.00 12,178,424.00 12,178,424.00 12,178,424.00 12,178,424.00 12,178,424.00 12,178,424.00 - 12,178,424.00 12,178,424.00
DEI Adjusted Shares Outstanding		 12,167,930.00 12,178,424.00 12,178,424.00 12,178,424.00 12,178,424.00 12,178,424.00 12,178,424.00 12,178,424.00 - 12,178,424.00 12,178,424.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.09 -0.08 -0.08 -0.06 -0.24 0.12 -0.07 -0.12 - -0.15 -0.33
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 44.68% 1,384.57% 512.95% 264.94% 370.76% 187.94% -21.09% -2.63% -55.81%
EBITDA Growth		 -4.45% 44.13% 2.42% 76.23% -96.67% 200.98% 2.69% -352.25% 11.13% -465.20% -859.80%
EBIT Growth		 -4.45% 38.62% 18.93% 60.55% -131.40% 150.89% 2.01% -174.87% 20.33% -783.06% -1,197.56%
NOPAT Growth		 2.26% 38.62% 18.93% 50.70% 134.46% -209.67% 2.02% -119.97% -634.96% -12.26% -1,197.56%
Net Income Growth		 -4.44% 34.10% 24.44% 50.75% -156.53% 251.77% 13.16% -104.52% 35.99% -223.20% -367.72%
EPS Growth		 0.00% 0.00% 0.00% 50.00% -166.67% 237.50% 50.00% -50.00% 54.17% -190.91% -450.00%
Operating Cash Flow Growth		 0.00% 43.28% 38.35% 28.57% 65.93% 162.90% 88.71% 12.46% 37.41% -331.73% -2,396.92%
Free Cash Flow Firm Growth		 38.97% 25.96% 0.00% 144.57% 397.44% -19.34% -441.18% -357.68% -221.00% -69.02% -0.09%
Invested Capital Growth		 43.66% 85.78% -26.22% -89.97% -175.02% -3.17% 119.09% 1,176.22% 221.11% 50.04% -57.09%
Revenue Q/Q Growth		 711.70% 30.76% -18.66% 71.96% 235.14% -22.15% 4.93% 5.18% -8.16% -3.93% -52.37%
EBITDA Q/Q Growth		 19.43% 22.36% -0.62% 62.24% -566.67% 139.86% -140.08% -75.50% -31.01% -63.81% 6.44%
EBIT Q/Q Growth		 23.87% 14.71% -2.70% 40.83% -346.50% 118.76% -155.50% -65.98% -29.42% -60.84% 5.89%
NOPAT Q/Q Growth		 23.87% 14.71% -2.70% 26.07% 153.21% -866.43% 18.44% -65.99% -29.42% -60.84% 5.89%
Net Income Q/Q Growth		 23.87% 14.70% -2.69% 26.15% -296.58% 150.47% -158.76% -73.92% -24.11% 2.86% -122.94%
EPS Q/Q Growth		 25.00% 11.11% 0.00% 25.00% -300.00% 145.83% -136.36% -125.00% -22.22% 9.09% -120.00%
Operating Cash Flow Q/Q Growth		 0.00% 66.37% -46.22% -60.85% 56.93% 162.09% -126.18% -1,147.65% 69.20% -129.88% -181.28%
Free Cash Flow Firm Q/Q Growth		 51.74% -10.01% 79.76% 514.84% 222.08% -144.14% -143.04% -97.53% -51.24% 38.34% 71.46%
Invested Capital Q/Q Growth		 14.44% -10.36% -55.25% -78.16% -956.16% 215.70% 1.25% 27.25% -18.75% 43.34% -71.04%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 48.00% 32.08% 16.52% 34.51% 63.77% 75.22% 56.58% 49.39% 27.75% 31.59% 25.60%
EBITDA Margin		 -429.21% -254.84% -315.26% -69.23% -137.72% 70.52% -65.17% -108.74% -155.11% -264.48% -519.59%
Operating Margin		 -429.21% -279.96% -353.48% -151.98% 24.13% -166.29% -73.57% -116.10% -163.60% -273.90% -541.24%
EBIT Margin		 -429.21% -279.96% -353.48% -121.62% -162.03% 39.04% -73.57% -116.10% -163.60% -273.90% -541.24%
Profit (Net Income) Margin		 -429.11% -279.93% -353.40% -151.77% -179.59% 116.41% -65.19% -107.80% -145.68% -147.30% -689.52%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 99.98% 99.99% 99.98% 124.79% 110.83% 298.16% 88.61% 92.85% 89.04% 53.78% 127.40%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% -96.38% -196.02% -123.24% 149.61% -278.47% -152.87% -305.69% -3,080.24% -373.85% -1,096.06%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -85.72% -186.25% -112.89% 434.13% -320.80% -150.76% -303.83% -3,078.22% -375.91% -1,091.02%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 52.76% 134.72% 72.37% -340.35% 254.92% 127.27% 282.72% 3,048.13% 341.42% 1,046.05%
Return on Equity (ROE)		 0.00% -43.62% -61.30% -50.87% -190.74% -23.55% -25.60% -22.97% -32.11% -32.43% -50.00%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% -245.17% -62.45% 0.00% -107.21% -170.05% -313.67% -354.80% -217.32% -382.50%
Operating Return on Assets (OROA)		 0.00% -40.36% -59.02% -25.89% -72.83% 11.76% -29.52% -26.39% -34.69% -46.00% -60.31%
Return on Assets (ROA)		 0.00% -40.36% -59.01% -32.30% -80.72% 35.07% -26.16% -24.50% -30.88% -24.74% -76.83%
Return on Common Equity (ROCE)		 0.00% -43.62% -61.30% -50.87% -190.74% -23.55% -25.60% -22.97% -32.11% -32.43% -50.00%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -157.41% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -0.79 -0.67 -0.69 -0.51 0.27 -2.09 -0.68 -1.13 -1.46 -2.34 -2.21
NOPAT Margin		 -300.45% -195.97% -247.43% -106.38% 16.89% -166.29% -51.50% -81.27% -114.52% -191.73% -378.87%
Net Nonoperating Expense Percent (NNEP)		 -16.50% -10.66% -9.77% -10.35% -284.52% 42.32% -2.12% -1.85% -2.01% 2.06% -5.04%
Return On Investment Capital (ROIC_SIMPLE)		 -16.20% -16.54% -30.41% -13.76% 22.30% -11.60% -3.79% -2.75% -3.57% -5.72% -3.87%
Cost of Revenue to Revenue		 52.00% 67.92% 83.48% 65.49% 36.23% 24.78% 43.42% 50.61% 72.25% 68.41% 74.40%
SG&A Expenses to Revenue		 229.64% 131.67% 226.72% 103.12% 23.01% 103.98% 118.38% 121.73% 120.13% 133.31% 386.08%
R&D to Revenue		 247.57% 180.37% 143.27% 83.37% 16.63% 37.53% 11.76% 43.75% 71.23% 72.18% 390.72%
Operating Expenses to Revenue		 477.21% 312.04% 369.99% 186.49% 39.64% 141.51% 130.15% 165.49% 191.35% 205.48% 776.80%
Earnings before Interest and Taxes (EBIT)		 -1.13 -0.96 -0.99 -0.59 -2.61 0.49 -0.97 -1.61 -2.08 -3.35 -3.15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -1.13 -0.88 -0.88 -0.33 -2.22 0.89 -0.86 -1.51 -1.97 -3.23 -3.02
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 11.78 19.39 22.53 0.00 5.29 12.04 6.35 7.52 5.90 6.85
Price to Tangible Book Value (P/TBV)		 0.00 11.81 19.44 22.61 0.00 5.29 12.05 6.35 7.52 5.90 6.85
Price to Revenue (P/Rev)		 0.00 43.87 48.01 28.23 34.39 26.25 46.21 46.66 58.70 45.50 87.44
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 16.18 43.48 172.46 0.00 37.23 92.60 80.74 120.29 62.39 360.75
Enterprise Value to Revenue (EV/Rev)		 0.00 42.79 46.60 27.13 34.09 21.88 42.84 39.81 51.32 38.40 74.88
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 34.40 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.26 0.31 0.00 1.17 -2.18 0.00 0.00 0.00 0.00 0.02 0.00
Long-Term Debt to Equity		 0.26 0.31 0.00 1.17 -2.18 0.00 0.00 0.00 0.00 0.02 0.00
Financial Leverage		 -0.50 -0.62 -0.72 -0.64 -0.78 -0.79 -0.84 -0.93 -0.99 -0.91 -0.96
Leverage Ratio		 1.27 1.31 1.31 1.95 4.26 1.14 1.15 1.15 1.24 1.07 1.07
Compound Leverage Factor		 1.27 1.31 1.31 2.44 4.72 3.40 1.02 1.07 1.10 0.57 1.36
Debt to Total Capital		 20.64% 23.91% 0.00% 53.91% 184.54% 0.00% 0.00% 0.00% 0.00% 2.18% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 20.64% 23.91% 0.00% 53.91% 184.54% 0.00% 0.00% 0.00% 0.00% 2.18% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 79.36% 76.09% 100.00% 46.09% -84.54% 100.00% 100.00% 100.00% 100.00% 97.82% 100.00%
Debt to EBITDA		 0.00 -0.23 0.00 -0.64 -0.52 0.00 0.00 0.00 0.00 -0.14 0.00
Net Debt to EBITDA		 0.00 0.21 0.00 0.48 0.19 0.00 0.00 0.00 0.00 5.84 0.00
Long-Term Debt to EBITDA		 0.00 -0.23 0.00 -0.64 -0.52 0.00 0.00 0.00 0.00 -0.14 0.00
Debt to NOPAT		 0.00 -0.29 0.00 -0.75 -1.40 0.00 0.00 0.00 0.00 -0.19 0.00
Net Debt to NOPAT		 0.00 0.27 0.00 0.56 0.50 0.00 0.00 0.00 0.00 7.81 0.00
Long-Term Debt to NOPAT		 0.00 -0.29 0.00 -0.75 -1.40 0.00 0.00 0.00 0.00 -0.19 0.00
Altman Z-Score		 0.00 9.66 11.55 2.01 3.47 42.03 85.67 89.11 104.64 58.56 63.11
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 6.21 3.31 2.22 1.53 9.27 32.76 24.59 52.38 48.80 26.10 30.32
Quick Ratio		 5.80 3.13 2.15 1.45 8.98 32.35 23.69 51.30 47.97 25.24 29.81
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -1.54 -1.69 -0.34 1.42 4.57 -2.02 -1.85 -3.66 -5.53 -3.41 -0.97
Operating Cash Flow to CapEx		 0.00% -259.33% -11,425.38% -46,550.00% -1,028.21% 565.91% -86.15% -388.10% -809.68% -291.41% -784.06%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 9.79 16.15 -7.03 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 -6.42 -1.42 0.87 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 -6.43 -1.55 0.71 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.14 0.17 0.21 0.45 0.30 0.40 0.23 0.21 0.17 0.11
Accounts Receivable Turnover		 0.00 0.00 7.37 8.21 3.58 5.62 9.13 7.09 4.50 4.71 6.85
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.63 0.63 0.99 1.94 2.58 3.47 4.13 4.08 4.02 3.39
Accounts Payable Turnover		 0.00 0.86 1.13 1.98 4.01 3.17 3.54 4.40 5.27 3.61 2.54
Days Sales Outstanding (DSO)		 0.00 0.00 49.50 44.45 101.95 64.94 39.98 51.46 81.13 77.46 53.27
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 422.18 322.22 184.76 91.12 115.03 103.16 83.00 69.24 101.04 143.84
Cash Conversion Cycle (CCC)		 0.00 -422.18 -272.72 -140.31 10.83 -50.09 -63.18 -31.54 11.89 -23.58 -90.57
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 2.46 2.20 0.99 0.22 -1.84 2.13 2.16 2.75 2.23 3.20 0.93
Invested Capital Turnover		 0.00 0.49 0.79 1.16 8.86 1.67 2.97 3.76 26.90 1.95 2.89
Increase / (Decrease) in Invested Capital		 0.75 1.02 -0.35 -1.93 -4.30 -0.07 1.17 2.53 4.07 1.07 -1.23
Enterprise Value (EV)		 0.00 36 43 37 93 79 200 222 268 200 334
Market Capitalization		 0.00 37 44 39 93 95 216 260 307 236 390
Book Value per Share		 $0.32 $0.25 $0.19 $0.14 ($0.08) $1.44 $1.36 $2.53 $2.28 $2.22 $3.22
Tangible Book Value per Share		 $0.32 $0.25 $0.18 $0.14 ($0.08) $1.44 $1.36 $2.53 $2.28 $2.22 $3.22
Total Capital		 4.88 4.08 2.28 3.72 1.22 18 18 41 41 41 57
Total Debt		 1.01 0.97 0.00 2.00 2.25 0.00 0.00 0.00 0.00 0.89 0.00
Total Long-Term Debt		 1.01 0.97 0.00 2.00 2.25 0.00 0.00 0.00 0.00 0.89 0.00
Net Debt		 -1.42 -0.90 -1.29 -1.50 -0.81 -16 -16 -38 -39 -37 -56
Capital Expenditures (CapEx)		 0.00 0.15 0.01 0.00 0.04 0.04 0.08 0.21 0.03 0.20 0.21
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.07 -0.38 -0.53 -2.11 0.98 0.83 0.89 1.31 0.87 0.86 -0.59
Debt-free Net Working Capital (DFNWC)		 2.35 1.50 0.77 1.40 4.04 17 17 39 39 39 55
Net Working Capital (NWC)		 2.35 1.50 0.77 1.40 4.04 17 17 39 39 39 55
Net Nonoperating Expense (NNE)		 0.34 0.29 0.30 0.22 3.17 -3.55 0.18 0.37 0.40 -0.54 1.81
Net Nonoperating Obligations (NNO)		 -1.42 -0.90 -1.29 -1.50 -0.81 -16 -16 -38 -39 -37 -56
Total Depreciation and Amortization (D&A)		 0.00 0.09 0.11 0.25 0.39 0.40 0.11 0.10 0.11 0.12 0.13
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% -45.48% -57.13% -154.04% 36.01% 23.00% 19.08% 23.51% 16.56% 16.46% -13.11%
Debt-free Net Working Capital to Revenue		 0.00% 179.66% 83.35% 102.06% 148.77% 460.35% 356.48% 708.49% 754.22% 743.55% 1,242.34%
Net Working Capital to Revenue		 0.00% 179.66% 83.35% 102.06% 148.77% 460.35% 356.48% 708.49% 754.22% 743.55% 1,242.34%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.09) ($0.08) ($0.08) ($0.06) ($0.24) $0.12 ($0.05) ($0.09) ($0.11) ($0.10) ($0.22)
Adjusted Weighted Average Basic Shares Outstanding		 12.17M 12.18M 12.30M 12.18M 12.21M 12.47M 13.17M 16.14M 17.88M 18.06M 17.67M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($0.08) ($0.06) ($0.24) $0.11 ($0.04) ($0.09) ($0.11) ($0.10) ($0.22)
Adjusted Weighted Average Diluted Shares Outstanding		 12.18M 12.18M 12.30M 12.18M 12.21M 13.21M 13.17M 16.14M 17.88M 18.06M 17.67M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 12.18M 12.18M 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 19.27M
Normalized Net Operating Profit after Tax (NOPAT)		 -0.79 -0.67 -0.69 -0.51 0.27 -1.46 -0.68 -1.13 -1.46 -2.34 -2.21
Normalized NOPAT Margin		 -300.45% -195.97% -247.43% -106.38% 16.89% -116.41% -51.50% -81.27% -114.52% -191.73% -378.87%
Pre Tax Income Margin		 -429.11% -279.93% -353.40% -151.77% -179.59% 116.41% -65.19% -107.80% -145.68% -147.30% -689.52%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 -4.03 -9.23 1.71 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 -3.53 0.96 -7.27 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 -4.05 -9.37 1.55 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 -3.54 0.82 -7.43 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% -0.08% -0.09% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Aeluma’s financial profile has improved substantially on liquidity and leverage, but the company remains unprofitable and its operating performance weakened in the latest quarter. Revenue increased from $32,000 in the first quarter of fiscal 2024 to $582,000 in the fourth quarter of fiscal 2026, although the latest result was well below the $1.39 million reported in the first quarter of fiscal 2026 and the $1.22 million in the third quarter.

  • Liquidity strengthened significantly. Cash and equivalents rose from approximately $1.9 million in March 2024 to $37.8 million by March 2026. The fourth quarter’s $20.1 million common-equity issuance produced a $18.2 million increase in cash during the quarter, providing additional funding for operations and development.
  • The balance sheet has moved from weak to well-capitalized. Total assets increased from $4.7 million in March 2024 to $42.5 million in March 2026, while total equity improved from $3.1 million to $40.1 million over the same period.
  • Leverage is relatively modest compared with the company’s asset base. Total liabilities were $2.4 million in the latest balance sheet, down substantially from $7.8 million in December 2024. The company also reported no preferred stock and no stated commitments or contingencies.
  • Gross margins remain positive. Aeluma generated $149,000 of gross profit on $582,000 of revenue in the latest quarter, representing a gross margin of approximately 26%. Gross margins were also positive in every quarter shown, despite considerable volatility.
  • Investment income is becoming a more meaningful offset to operating losses. Interest and investment income increased from negligible amounts in fiscal 2024 to $359,000 in the latest quarter, reflecting the company’s larger cash balance. However, this income is non-operating and depends on maintaining substantial cash reserves.
  • Capital spending has remained controlled. Quarterly purchases of property, plant and equipment generally ranged from roughly $2,000 to $310,000. This limits near-term capital requirements, although it may also indicate that production capacity is still developing.
  • Operating losses have persisted and recently widened. Aeluma reported net losses in every fiscal 2026 quarter, increasing from $1.49 million in the first quarter to $4.01 million in the fourth quarter. The latest loss translated to a basic and diluted loss of $0.22 per share.
  • Revenue momentum deteriorated sharply in the latest quarter. Quarterly revenue declined from $1.39 million in Q1 fiscal 2026 to $1.27 million, $1.22 million and then $582,000 in Q4. The latest quarter’s revenue was approximately 53% below the third-quarter level.
  • Operating expenses substantially exceed gross profit. Selling, general and administrative expense was $2.25 million and research and development expense was $2.27 million in Q4 fiscal 2026, compared with only $149,000 of gross profit. The resulting operating loss was $3.15 million.
  • The company continues to consume cash from operations and relies heavily on equity financing. Operating cash flow was negative in each fiscal 2026 quarter, including negative $1.62 million in Q4. Meanwhile, Aeluma raised $23.4 million through common equity in Q1 and another $20.1 million in Q4, increasing the share count and creating dilution risk for existing investors.

Overall, Aeluma has considerably more financial flexibility than it did two years ago, with a large cash balance, positive equity and reduced liabilities. The key investment question is whether management can convert that funding into sustained revenue growth and eventually positive operating cash flow. Until that occurs, the company’s strong liquidity is primarily a buffer against continued losses rather than evidence of a self-sustaining business.

09/23/26 02:37 AM ETAI Generated. May Contain Errors.

Aeluma Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Aeluma's financial year ends in June. Their financial year 2026 ended on June 30, 2026.

Aeluma's net income appears to be on an upward trend, with a most recent value of -$9.16 million in 2026, rising from -$2.69 million in 2022. The previous period was -$3.02 million in 2025. Find out what analysts predict for Aeluma in the coming months.

Aeluma's total operating income in 2026 was -$10.19 million, based on the following breakdown:
  • Total Gross Profit: $1.57 million
  • Total Operating Expenses: $11.76 million

Over the last 4 years, Aeluma's total revenue changed from $0.00 in 2022 to $4.46 million in 2026, a change of 446,100,000.0%.

Aeluma's total liabilities were at $3.73 million at the end of 2026, a 147.5% increase from 2025, and a 2,423.2% increase since 2020.

In the past 6 years, Aeluma's cash and equivalents has ranged from $38.30 thousand in 2020 to $56.01 million in 2026, and is currently $56.01 million as of their latest financial filing in 2026.

Over the last 4 years, Aeluma's book value per share changed from 0.48 in 2022 to 3.22 in 2026, a change of 572.9%.


Related Companies

Financial statements for NASDAQ:ALMU last updated on 9/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel
Bank of America: 'Digital Dollar Inevitable'
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel